论文部分内容阅读
目的:探讨支气管哮喘的临床诊断和治疗。方法:选取79例支气管哮喘患者,随机分为两组,观察组42例,对照组37例,对所有患者进行常规治疗的基础上,观察组患者采用阿托品联合非那根进行治疗,对照组仅采用阿托品进行治疗,对两组患者的治疗过程进行跟踪观察,并记录所得数据。结果:经过治疗,两组患者的病情均得到了一定程度的改善,观察组有效率为92.9%,对照组有效率为78.4%,观察组患者的治疗效果要显著优于对照组P<0.05,差异有统计学意义。结论:在治疗支气管哮喘疾病的过程中,采用阿托品联合非那根进行治疗效果较为显著,对于促进患者病情的改善和生活质量的提高有较大帮助,值得临床推广应用。
Objective: To investigate the clinical diagnosis and treatment of bronchial asthma. Methods: A total of 79 patients with bronchial asthma were randomly divided into two groups: observation group (n = 42) and control group (n = 37). All patients were treated routinely. Patients in observation group were treated with atropine plus phenazon. Atropine treatment, follow-up observation of the treatment of two groups of patients, and record the data obtained. Results: After treatment, the two groups of patients had a certain degree of improvement, the observation group, the effective rate was 92.9%, the control group, the effective rate was 78.4%, the observation group, the treatment effect was significantly better than the control group P <0.05, The difference was statistically significant. Conclusion: In the process of treating bronchial asthma, the treatment with atropine and phenazon is significant, which is helpful to improve the patients’ condition and improve the quality of life, which is worthy of clinical application.